BenQ Medical Technology (ROCO:4116) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:4116 BenQ Medical Technology Corp ROCO:4116
81 GF Score
Price NT$38.60
GF Value NT$62.38
Valuation Significantly Undervalued
! 6 Warning Signs
View Full Analysis

What is BenQ Medical Technology FFO?

FFO (Funds from operations) only applies to REITs.

ROCO:4116
81GF Score
BenQ Medical Technology Corp ROCO:4116
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is BenQ Medical Technology (ROCO:4116) Overvalued in 2026?

Based on GuruFocus' analysis, BenQ Medical Technology stock appears to be undervalued. The current stock price of NT$38.60 is trading 38.1% below its estimated GF Value™ of NT$62.38. GuruFocus considers BenQ Medical Technology to be Significantly Undervalued.

Key valuation signals for ROCO:4116:

  • FFO:
  • GF Value™: NT$62.38 vs. price of NT$38.60 (38.1% below fair value)
  • GF Score™: 81/100 with 6 warning signs

No single metric tells the full story. See the ROCO:4116 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

BenQ Medical Technology Business Description

Address No.46, Zhouzi Street, 7th Floor, Neihu District, Taipei, TWN, 11493
BenQ Medical Technology Corp is engaged in the manufacturing, assembly, maintenance, repair, and sales of professional medical equipment and consumables. Its products include surgical and gynecology tables, digital OR solutions, halogen and LED surgical lights, and medical imaging products, among others. The company's segment includes the R&D and Manufacturing Division and the Medical Services Division. The company generates the majority of its revenue from the Medical Services Division. Geographically, the company generates revenue from Taiwan, Mainland China, Indonesia, Thai, India, Colombia, and Others.
81GF Score

Get the complete analysis for ROCO:4116

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$38.60
Price
NT$62.38
GF Value